Each year, the Royal Society recognises exceptional research achievements through a series of prestigious medals and prizes named after great scientists of the past. This year eight Oxford University researchers, six of them from MPLS Division, have been honoured for their outstanding contributions to science and medicine.
A team led by researchers from Oxford Chemistry have recently published a study in Nature Communications investigating the mechanism behind a resistance to the drug ivosidenib that has developed in some types of cancer.
The StEP programme gives students the opportunity to have a go at becoming an entrepreneurs, challenging students to identify an idea for a new business based on a University research project, develop a business plan, and prepare a pitch to real investors - all in just four weeks.
Members of MPLS departments were amongst those recognised at the University's seventh Environmental Sustainability Awards today, hosted by Vice Chancellor, Dame Professor Louise Richardson.
Oxford Chemistry students with innovative, game-changing ideas have been highlighted at the inaugural Jamie Ferguson Chemistry Innovation Awards ('The Jamies'), a new annual awards scheme co-developed by the Department of Chemistry and Oxford University Innovation (OUI) in honour of the late Dr Jamie Ferguson.
Funding to train the next generation of cutting-edge antimicrobial resistance researchers has been announced by Ineos Oxford Institute (IOI), the University of Oxford, and the University of Cambridge.
Professors Andrew Goodwin and Iain McCullogh in the Department of Chemistry are part of the team of 10 researchers at the Universities of Oxford and Cambridge that will be at the forefront of work that on a new generation of soft functional materials.
This award has been created as a legacy to Dr Jamie Ferguson of Oxford University Innovation, who tragically died in August 2020 after succumbing to COVID-19.
A publication by University of Oxford researchers describes a new minimally invasive and inexpensive blood test that can identify cancer in patients with non-specific symptoms.
Scientists have discovered a new potential treatment that has the ability to reverse antibiotic resistance in bacteria that cause conditions such as sepsis, pneumonia, and urinary tract infections.
The Innovation Centre for Applied Sustainable Technologies (iCAST), a \u00a317m collaboration aiming to translate sustainable chemical technology research into commercial products, recently launched in Swindon.
Oxford chemists have made a breakthrough towards successfully producing sustainable aviation fuel directly from air (CO2 source) and water (H2 source).
Oxford Nanopore Technologies, a company which began as a spinout from the Department of Chemistry, has floated on the London Stock Exchange. It is the UK's biggest spinout IPO and the 5th biggest worldwide.
AMR could render many of the current mainstay and last-resort antibiotics useless, resulting in many more deaths from previously treatable infections. In 2019, a UN report estimated that drug-resistant microbes could lead to ten million deaths per year, and cost the world $100trn, by 2050.
An international collaboration of 29 scientists around the world has focused on understanding how SARS-COV-2 makes its worker proteins at the molecular level in order to develop novel antiviral drugs that block their production.
Five of the new Fellows are from MPLS Division. The Fellowships have been created by UKRI to help develop the next wave of world-class research and innovation leaders in academia and business.
![\"Royal](\"https://www.mpls.ox.ac.uk/latest/news/six-mpls-researchers-honoured-with-royal-society-medals/responsive_image?ratio=r16x9&scale=w760\")
\n \n \n\n\n